Industry Explorers Blaze On
-
Rescuing A Company’s Core Purpose
10/2/2023
When Dr. Scott Braunstein moved from his position as chairman of the board and interim CEO to become permanent CEO of Marinus Pharmaceuticals in August 2019, he had already concluded an overbroad focus was holding the company back.
-
Insights On Today’s Biotech Market Conditions
10/2/2023
At Locust Walk, we regularly compile key statistics to illustrate trends in the private and public markets, overall activity levels, and what deals M&A and strategic partnering participants are pursuing. This analysis offers the opportunity for data-driven insights on the current market conditions, how they compare to historic levels, and what they mean for the future.
-
Using AI To Find And Develop Safer Medicines
10/2/2023
Montai Health CEO Margo Georgiadis is using what she’s learned at McKinsey, Discover, Google, Mattel, and Ancestry to reinvent drug discovery and development, with a focus on long-term safety.
-
Companies To Watch: Spruce Biosciences
10/2/2023
Spruce Biosciences is currently in mid-to-late stage clinical development of new agents to treat rare endocrine disorders.
-
I Could’ve Used A Mentorship Group … So I Created One
10/2/2023
Carolina Serrano Martinez realized that she could leverage her experience to build something that would create opportunities for those that looked like her, and those who didn’t.
-
Why Adaptability Is An Essential Leadership Skill
10/2/2023
Leaders must constantly assess their team as both a unit and individuals for their ability to take obstacles in stride, pivot, and execute a new plan based on the changing environment.
-
Establishing A Research Function In Biopharma
10/2/2023
When it was time to double-down on development efforts to feed its pipeline of biologics, Horizon Therapeutics turned to Big Biopharma veteran Robert Stoffel, Ph.D. to lead the effort. Stoffel joined us for an episode of the Business of Biotech podcast to share how he did it.
-
Life Biosciences Grows Up: A Q&A With Jerry McLaughlin
10/2/2023
Through the boom and bust of anti-aging buzz cycles, Life Biosciences has continued its focus on epigenetic reprogramming with an increasingly focused pipeline and development strategy.
-
Leadership Pressures: Causing An Imbalanced Organization
9/1/2023
We all must do what’s best for our business, our teams (people), and ultimately the patient in a compliant manner. So, what happens if you prioritize one over the other?
-
How Program Managers Can Help Reach Development Milestones
9/1/2023
Though commonly misunderstood, the program manager fuses the varied projects within the larger program and strategically places them into an integrated development plan so companies can successfully reach (and announce via press releases) each milestone while preparing for the next.